Manifold
The AI Platform for Life Sciences
Published Aug 22, 2026
Quantitative market share data was not available in the captured sources. The vendor's public statements claim engagement with many organizations and a large user base, but these are vendor claims and should be validated through references and independent data.
| Starting Price | Not public (contact sales) | Enterprise subscription examples referenced via marketplace listings | Not public (customized; contact sales) |
| Best For | Regulated life-sciences organizations needing a TRE, multimodal data unification, governed collaboration, and AI-assisted workflows | Genomics-heavy pipelines, secure data sharing, bioinformatics workflow execution at scale | Biotech R&D teams needing a central R&D cloud platform with ELN/LIMS capabilities |
| Key Strength | Vendor positions the platform as governance-first TRE functionality combined with automation features and partner collaboration capabilities | Deep genomics workflow ecosystem and established presence in genomics operations | Strong biotech R&D platform footprint with significant adoption in the biotech sector |
| Key Weakness | Limited public pricing and limited third-party review corpus; many claims are vendor-supplied and require external validation | Can be costly at enterprise scale; enterprise terms and usage rates are negotiated | May be less suited as a full TRE for cross-institution clinical research governance depending on use case; pricing details often require sales engagement |
—
Manifold vs DNAnexus
Manifold vs Benchling
Manifold vs Palantir Foundry + AIP